DiAGSure® Zika virus TaqMan PCR kit

Catalog No.: GDQ6057-20R, GDQ6057-50R, GDQ6057-100R
Intended Use:
Zika virus, transmitted primarily by Aedes mosquitoes, is a major public health threat due to its link with congenital birth defects and neurological complications. Though often mild or asymptomatic, Zika infection can present with fever, rash, conjunctivitis, muscle pain, and joint pain. The virus is especially dangerous during pregnancy, as it may cause microcephaly and other serious fetal brain abnormalities. Early and precise detection is vital for clinical decision-making, outbreak containment, and protecting vulnerable populations. The DiAGSure® Zika Detection Kit is a real-time PCR-based molecular assay that ensures highly sensitive and specific detection of Zika virus RNA. The kit comes with pre-formulated reagents, internal controls for result validation, and is optimized for seamless use with standard PCR platforms. It is an essential diagnostic solution for clinicians and laboratories involved in Zika virus surveillance, patient care, and maternal health protection.

Key Specifications:
 Detects Zika Virus (ZIKV) RNA—linked to congenital Zika syndrome, microcephaly, Guillain-Barré syndrome, and other neurological complications.
 Enables early diagnosis during acute febrile phase, even in asymptomatic or low-viral-load cases.
 High sensitivity and specificity ensure accurate detection across diverse ZIKV strains.
 Mutation-resilient assay design minimizes false negatives due to genetic variation.
 Includes ready-to-use Master Mix with internal control for streamlined, contamination-free workflow.
 Fully compatible with major real-time PCR platforms for flexible laboratory integration.
 Clinically validated and CDSCO approved—ideal for prenatal screening, outbreak response, and routine diagnostics.

Sample types:
Cerebrospinal fluid, Whole blood or blood culture, stool and throat swabs.

Product information: